Peter Lanbeck Selected Research

Dicloxacillin (Dycill)

4/2015	Do surface active parenteral formulations cause inflammation?
2/2004	Dicloxacillin and erythromycin at high concentrations increase ICAM-1 expression by endothelial cells: a possible factor in the pathogenesis of infusion phlebitis.
1/2003	Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis.
1/2002	Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Lanbeck Research Topics

Disease

5	Phlebitis 04/2015 - 01/2002
3	Sepsis (Septicemia) 01/2020 - 10/2016
1	Vomiting 01/2020
1	Infections 07/2017
1	Communicable Diseases (Infectious Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

7	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2002
4	Dicloxacillin (Dycill)FDA LinkGeneric 04/2015 - 01/2002
3	Erythromycin (Erycette)FDA LinkGeneric 04/2015 - 01/2002
2	Cloxacillin (Tegopen)FDA Link 01/2003 - 01/2002
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Anti-Infective Agents (Microbicides)IBA 02/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2004
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2002
1	Cefuroxime (Zinacef)FDA LinkGeneric 01/2002
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2002
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2002
1	Netilmicin (Netromycin)FDA Link 01/2002
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 01/2002
1	Vancomycin FDA LinkGeneric 01/2002
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 01/2002

Therapy/Procedure

2	Catheters 01/2004 - 01/2003
1	Length of Stay 07/2017
1	Therapeutics 10/2016
1	Intravenous Administration 01/2002